Inhibitor of β‐catenin and T‐cell factor (ICAT) promotes colorectal cancer (CRC) cell migration and invasion by interacting with the junction plakoglobin (JUP) and via the NF‐κB signaling pathway in CRC. Here, JUP is linked to colorectal carcinoma.